ClinicalTrials.Veeva

Menu

Assessing the Efficacy of Probiotics in Prevention of NEC in Preterm Babies

H

Hayatabad Medical Complex

Status

Not yet enrolling

Conditions

NEC - Necrotizing Enterocolitis
NEC

Treatments

Drug: Probiotic
Drug: 10% dextrose

Study type

Interventional

Funder types

Other

Identifiers

NCT07233382
Agha Khan (Other Grant/Funding Number)
ERB # 2731

Details and patient eligibility

About

The goal of the study is to check efficacy of probiotics in preventing necrotizing enterocolitis. The main questions would be if the preterm baby developed NEC or not.

Full description

: In the last five years, many systematic reviews have shown the benefit of Probiotics in prevention of NEC and Sepsis in preterm babies but most of these studies have been done in the developed countries. Although the overall benefit has been tilted In favor of use of probiotic however a definitive consensus has not been reached due to inconsistencies in results. Moreover, the impact of multistrain probiotics in our particular population has not been studied, which provides the rationale for our research

Enrollment

196 estimated patients

Sex

All

Ages

Under 1 day old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male and female preterm infants with a gestational age less than 35 weeks.
  • All indoor patients and outdoor patients who present within 24hrs of birth

Exclusion criteria

  • • Infants with congenital or developmental gastrointestinal disorders for example omphalocele, malrotation, gastroschisis.

    • Infants with severe sepsis or gastrointestinal bleeding on presentation

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

196 participants in 2 patient groups, including a placebo group

Probiotic group - Intervention
Active Comparator group
Description:
This group will receive intervention
Treatment:
Drug: Probiotic
Placebo
Placebo Comparator group
Description:
This group will receive 10% DW
Treatment:
Drug: 10% dextrose

Trial contacts and locations

0

Loading...

Central trial contact

Romisa Rehman, MBBS, FCPS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems